Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Landos Biopharma, Inc. | 14,869,915 | reported | 09 Feb 2021 | tx 10+14,869,915−13,369,728 |
| Kadmon Holdings, LLC | 205,000 | reported | 08 Dec 2017 | tx 6+559,000 |
| Lyra Therapeutics, Inc. | 30,000 | reported | 13 Jun 2024 | tx 5+79,000 |
| LianBio | 0 | reported | 15 Feb 2024 | tx 5+108,900−55,518 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2024 | GRANT_AWARD | Lyra Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 15 Feb 2024 | TAX_WITHHOLDING | LianBio | 19,218 | 4.76 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 2.52 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Lyra Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 08 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 34,611 | 11.38 USD | |
| 08 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 86,671 | 12.53 USD | |
| 08 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 1,771 | 13.10 USD | |
| 09 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 64,730 | 13.80 USD | |
| 09 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 34,951 | 14.60 USD | |
| 05 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 27,453 | 11.14 USD | first after silence |
| 08 Feb 2021 | PURCHASE | Landos Biopharma, Inc. | 1,250,000 | 16.00 USD | |
| 08 Feb 2021 | CONVERSION | Landos Biopharma, Inc. | 13,369,728 | — | |
| 08 Feb 2021 | CONVERSION | Landos Biopharma, Inc. | 5,883,538 | — | deriv |
| 08 Feb 2021 | CONVERSION | Landos Biopharma, Inc. | 7,486,190 | — | deriv |
| 30 Apr 2020 | GRANT_AWARD | Lyra Therapeutics, Inc. | 14,500 | 0.00 USD | deriv |
| 08 Dec 2017 | GRANT_AWARD | Kadmon Holdings, LLC | 205,000 | 0.00 USD | deriv |
| 15 Dec 2016 | GRANT_AWARD | Kadmon Holdings, LLC | 350,000 | 4.66 USD | deriv |
| 11 Nov 2016 | PURCHASE | Kadmon Holdings, LLC | 1,000 | 5.43 USD | |
| 11 Nov 2016 | PURCHASE | Kadmon Holdings, LLC | 1,000 | 5.95 USD | |
| 11 Nov 2016 | PURCHASE | Kadmon Holdings, LLC | 1,000 | 5.96 USD |
1 purchase reported after at least 12 months of silence — most recent on 05 Feb 2021.